Orthopedic Growth Factor Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Cervical Disc Degeneration Market, Tibial Fracture Market, and 2 more

The global orthopedic growth factor market was valued at $1.05 billion in 2024 and is projected to grow at a CAGR of 2.2%, reaching $1.2 billion by 2031.

This market is segmented by indication type, including:

• Cervical Disc Degeneration
• Tibial Fractures
• Spine
• Ankle & Hindfoot Fusion

Market Insights & Data Coverage

• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Landscape, Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends

• Impact of COVID-19 on Market Growth:

* The COVID-19 pandemic led to a decline in sales due to canceled elective surgeries in 2020.

* Despite this temporary disruption, the market recovered strongly by 2022 and returned to steady growth.

• Continued Demand for Spinal Fusion Therapies:

* Spinal fusion remains a key driver of growth for orthopedic growth factors.

* Ongoing clinical research supports the efficacy of growth factors in bone healing and spinal procedures.

• Regulatory Approvals Expanding Market Reach:

* Companies are securing FDA approvals for expanded indications, leading to wider adoption of orthopedic growth factors.

* Recent approvals have fueled growth in the cervical disc degeneration and hindfoot/ankle fusion segments.

Market Share Insights

Top Competitors in the Global Orthopedic Growth Factor Market (2024):

1 Medtronic

* Market leader in the orthopedic growth factor segment.

* INFUSE(R) remains the gold standard for spinal fusion therapies.

2 Cerapedics

* Second-largest market share with its i-Factor(TM) product.

* Expanded FDA approval allows i-Factor(TM) to be used in single-level anterior cervical discectomy fusion (ACDF) with an allograft bone ring or fusion interbody device.

3 Stryker

* Third-largest competitor, known for its AUGMENT(R) product line.

* AUGMENT(R) is the first and only FDA-approved alternative to autograft for hindfoot and ankle arthrodesis.

Market Segmentation Summary

Cervical Disc Degeneration Market

• Growth factors aiding in cervical spine fusion procedures.

Tibial Fracture Market

• Orthopedic growth factors used in tibial fracture repair and bone healing.

Spine Market

• Key segment driven by spinal fusion procedures.

Ankle & Hindfoot Fusion Market

• Focus on bone regeneration and fusion techniques for foot and ankle disorders.

Global Research Scope

• Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size, Market Shares
• Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices
• Procedure Numbers

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends & Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls, Disruptive Technologies
• Disease Overviews

Data Sources:

• Primary Interviews with Industry Leaders
• Government Physician Data & Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database